# Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain

> **NCT02946073** · PHASE3 · COMPLETED · sponsor: **Braeburn Pharmaceuticals** · enrollment: 1053 (actual)

## Conditions studied

- Chronic Lower Back Pain
- Chronic Pain

## Interventions

- **DRUG:** buprenorphine
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02946073
- **Lead sponsor:** Braeburn Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-05
- **Final completion:** 2019-02
- **Target enrollment:** 1053 (ACTUAL)
- **Last updated:** 2021-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02946073

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02946073, "Buprenorphine (CAM2038) in Subjects With a Recent History of Moderate to Severe Chronic Low Back Pain". Retrieved via AI Analytics 2026-09-17 from https://api.ai-analytics.org/clinical/NCT02946073. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*